Maxim Group Downgrades Abeona Therapeutics (ABEO) to Hold
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy downgraded Abeona Therapeutics (NASDAQ: ABEO) from Buy to Hold.Abeona reported 2Q19 (on 8/9/19) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
